February 26, 2013 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology appropriateness criteria. These continually updated criteria are a national standard developed by expert panels of physicians from many different medical specialties.

In the latest version, the ACR updated 23 appropriateness criteria topics and added four new criteria — pulmonary hypertension; renal transplant dysfunction; management of locoregionally advanced squamous cell carcinoma of the vulva; and treatment of Stage I T1 glottic cancer. ACR appropriateness criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have also been shown to improve quality, reduce unnecessary exams and lower costs. 

“Choosing the most appropriate radiation therapy strategy is essential to the effective and safe treatment of many cancer patients. Use of ACR appropriateness criteria can aid physicians in doing so by providing the latest evidence-based approach for a wide variety of radiotherapy issues,” said Benjamin Movsas, M.D., FACR, chair of the ACR Committee on Radiation Oncology Appropriateness Criteria.

ACR appropriateness criteria provide a tool for more effective clinical decision making to help ensure that imaging is neither over nor underutilized. The guidelines are developed by expert panels in diagnostic imaging, interventional radiology and radiation oncology. Each panel includes leaders in radiology and other specialties. Currently, there are 186 topics with over 900 variants available.

“ACR appropriateness criteria are the most comprehensive evidence-based guidelines available for selection of diagnostic imaging and image-guided interventional procedures. Not only do these guidelines aid referring physicians and other providers in choosing the most appropriate diagnostic imaging and interventional procedures for a wide variety of clinical conditions, they can reduce unnecessary patient and population exposure to radiation, a growing concern of many Americans. I urge every provider to familiarize themselves with these guidelines before making a diagnostic imaging or image-guided interventional treatment decision,” said E. Kent Yucel, M.D., FACR, chair of the ACR Committee on Diagnostic Imaging and Interventional Radiology Appropriateness Criteria.

For more information: acr.org/Quality-Safety/Appropriateness-Criteria

 

 


Related Content

News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
Subscribe Now